Rossari Biotech Limited

NSEI:ROSSARI Stock Report

Market Cap: ₹43.5b

Rossari Biotech Management

Management criteria checks 4/4

Rossari Biotech's CEO is Sunil Chari, appointed in Jan 2003, has a tenure of 21.92 years. total yearly compensation is ₹12.13M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 30.87% of the company’s shares, worth ₹13.41B. The average tenure of the management team and the board of directors is 5.1 years and 3.3 years respectively.

Key information

Sunil Chari

Chief executive officer

₹12.1m

Total compensation

CEO salary percentage100.0%
CEO tenure21.9yrs
CEO ownership30.9%
Management average tenure5.1yrs
Board average tenure3.3yrs

Recent management updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Recent updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Jun 14
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

May 07
Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

CEO Compensation Analysis

How has Sunil Chari's remuneration changed compared to Rossari Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹1b

Jun 30 2024n/an/a

₹1b

Mar 31 2024₹12m₹12m

₹1b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹11m₹11m

₹1b

Dec 31 2022n/an/a

₹1b

Sep 30 2022n/an/a

₹995m

Jun 30 2022n/an/a

₹1b

Mar 31 2022₹10m₹10m

₹977m

Dec 31 2021n/an/a

₹957m

Sep 30 2021n/an/a

₹948m

Jun 30 2021n/an/a

₹892m

Mar 31 2021₹9m₹9m

₹802m

Dec 31 2020n/an/a

₹729m

Sep 30 2020n/an/a

₹695m

Jun 30 2020n/an/a

₹666m

Mar 31 2020₹8m₹7m

₹653m

Mar 31 2019₹5mn/a

₹457m

Mar 31 2018₹9mn/a

₹254m

Compensation vs Market: Sunil's total compensation ($USD142.04K) is below average for companies of similar size in the Indian market ($USD269.00K).

Compensation vs Earnings: Sunil's compensation has been consistent with company performance over the past year.

CEO

Sunil Chari (59 yo)

21.9yrs

Tenure

₹12,130,000

Compensation

Mr. Sunil Srinivasan Chari serves as a Managing Director of Rossari Biotech Limited since September 26, 2019 and serves as its Director since 2009. He is a co-founder of Rossari Biotech Limited in 2003. He...

Leadership Team

NamePositionTenureCompensationOwnership
Edward Menezes
Co-Founder & Executive Chairman15.9yrs₹12.13m31.13%
₹ 13.5b
Sunil Chari
Co-Founder21.9yrs₹12.13m30.87%
₹ 13.4b
Ketan Sablok
Chief Financial Officer1.6yrsno datano data
Mikhail Menezes
Director of Technicalno datano data0.24%
₹ 104.6m
Parul Gupta
Company Secretary & Compliance Officer5.1yrs₹1.00mno data
Sunil Nair
Chief Human Resource Officer & Head Corporate Communicationsless than a yearno datano data
Yash Chari
Director of Marketing & Business Developmentno datano data0.30%
₹ 129.5m
Puneet Arora
Chief Executive Officer of Textile Chemicals Globalno datano datano data
Prasad Gadkari
President of Manufacturingno datano datano data

5.1yrs

Average Tenure

49yo

Average Age

Experienced Management: ROSSARI's management team is seasoned and experienced (5.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Edward Menezes
Co-Founder & Executive Chairman15.9yrs₹12.13m31.13%
₹ 13.5b
Sunil Chari
Co-Founder15.9yrs₹12.13m30.87%
₹ 13.4b
Aseem Dhru
Independent Director5.1yrs₹2.87m0.00018%
₹ 78.2k
Annoottam Ghosh
Member of Advisory Boardno datano datano data
Vikram Gupta
Member of Advisory Boardno datano datano data
Jean Marcopoulos
Member of Advisory Boardno datano datano data
Klaus Karl
Member of Advisory Boardno datano datano data
Aparna Sharma
Non-Executive Independent Director1.6yrs₹2.93mno data
Esha Achan
Additional Non-Executive Independent Director1.2yrs₹1.13mno data
Gurudas Aras
Non- Executive Independent Directorless than a yearno datano data

3.3yrs

Average Tenure

59yo

Average Age

Experienced Board: ROSSARI's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 22:11
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rossari Biotech Limited is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAnand Rathi Shares and Stock Brokers Limited
Bhawana IsraniAnand Rathi Shares and Stock Brokers Limited
Rohit NagrajCentrum Broking Limited